Variant report

Variant	esv3314604
Chromosome Location	chr17:20823273-20825766
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:20825594-20826007	K562	blood:	n/a	n/a
2	BACH1	chr17:20825619-20825937	K562	blood:	n/a	n/a
3	BHLHE40	chr17:20825686-20825932	K562	blood:	n/a	n/a
4	EP300	chr17:20825645-20826026	K562	blood:	n/a	chr17:20825711-20825720 chr17:20825863-20825872
5	EP300	chr17:20825376-20826167	SK-N-SH	brain:	n/a	chr17:20825711-20825720 chr17:20825863-20825872
6	EP300	chr17:20824077-20824482	Hela-S3	cervix:	n/a	n/a
7	FOS	chr17:20825541-20825946	MCF10A-Er-Src	breast:	n/a	chr17:20825862-20825872 chr17:20825623-20825634 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
8	FOS	chr17:20825481-20826068	HUVEC	blood vessel:	n/a	chr17:20825862-20825872 chr17:20825623-20825634 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
9	FOS	chr17:20825478-20826027	MCF10A-Er-Src	breast:	n/a	chr17:20825862-20825872 chr17:20825623-20825634 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
10	FOS	chr17:20825501-20825780	MCF10A-Er-Src	breast:	n/a	chr17:20825623-20825634
11	FOS	chr17:20825477-20826027	MCF10A-Er-Src	breast:	n/a	chr17:20825862-20825872 chr17:20825623-20825634 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
12	FOSL1	chr17:20825747-20826025	K562	blood:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
13	FOSL2	chr17:20825454-20825881	SK-N-SH	brain:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
14	FOSL2	chr17:20825408-20826189	SK-N-SH	brain:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
15	GATA3	chr17:20825460-20826177	SK-N-SH	brain:	n/a	n/a
16	GATA3	chr17:20825380-20826200	SK-N-SH	brain:	n/a	n/a
17	GTF2F1	chr17:20825740-20826019	Hela-S3	cervix:	n/a	n/a
18	HCFC1	chr17:20825614-20825841	K562	blood:	n/a	n/a
19	IRF1	chr17:20824390-20824408	K562	blood:	n/a	n/a
20	JUN	chr17:20825469-20826162	K562	blood:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
21	JUND	chr17:20825311-20826087	SK-N-SH	brain:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
22	JUND	chr17:20825516-20826083	Hela-S3	cervix:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
23	JUND	chr17:20825460-20826074	K562	blood:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
24	JUND	chr17:20825387-20826195	SK-N-SH	brain:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
25	JUND	chr17:20825396-20826190	SK-N-SH	brain:	n/a	chr17:20825862-20825872 chr17:20825864-20825875 chr17:20825862-20825872 chr17:20825862-20825872 chr17:20825863-20825871 chr17:20825863-20825870 chr17:20825862-20825872 chr17:20825863-20825871
26	MAFF	chr17:20825603-20825955	K562	blood:	n/a	n/a
27	MAFK	chr17:20825574-20825946	K562	blood:	n/a	n/a
28	MAX	chr17:20825435-20826043	SK-N-SH	brain:	n/a	chr17:20825863-20825872
29	MAX	chr17:20825724-20825990	Hela-S3	cervix:	n/a	chr17:20825863-20825872
30	MAZ	chr17:20825737-20826081	K562	blood:	n/a	chr17:20825863-20825872
31	MAZ	chr17:20825736-20825998	Hela-S3	cervix:	n/a	chr17:20825863-20825872
32	MYC	chr17:20825571-20826044	K562	blood:	n/a	chr17:20825863-20825872
33	PBX3	chr17:20825459-20826083	SK-N-SH	brain:	n/a	n/a
34	PBX3	chr17:20825412-20826071	SK-N-SH	brain:	n/a	n/a
35	PBX3	chr17:20823893-20824502	SK-N-SH	brain:	n/a	n/a
36	POLR2A	chr17:20823136-20823396	K562	blood:	n/a	n/a
37	POLR2A	chr17:20825411-20825904	SK-N-SH	brain:	n/a	n/a
38	POLR2A	chr17:20825610-20825788	MCF10A-Er-Src	breast:	n/a	n/a
39	POLR2A	chr17:20824194-20824287	HepG2	liver:	n/a	n/a
40	POLR2A	chr17:20825634-20825813	K562	blood:	n/a	n/a
41	POLR2A	chr17:20823808-20823982	H1-hESC	embryonic stem cell:	n/a	n/a
42	POLR2A	chr17:20825594-20826063	U87	brain:	n/a	n/a
43	POLR2A	chr17:20823731-20824519	SK-N-SH	brain:	n/a	n/a
44	POLR2A	chr17:20823178-20823873	HepG2	liver:	n/a	n/a
45	RAD21	chr17:20825722-20825988	Hela-S3	cervix:	n/a	chr17:20825765-20825777
46	RCOR1	chr17:20825713-20826049	Hela-S3	cervix:	n/a	n/a
47	RCOR1	chr17:20825625-20826086	K562	blood:	n/a	n/a
48	RFX5	chr17:20825739-20826169	Hela-S3	cervix:	n/a	n/a
49	SMC3	chr17:20824301-20824378	HepG2	liver:	n/a	n/a
50	SMC3	chr17:20825734-20825937	Hela-S3	cervix:	n/a	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:20825547..20827539-chr17:20831716..20833822,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DHRS7B-5	chr17:20824338-20824482	XLOC_012139
2	lnc-DHRS7B-5	chr17:20824358-20824482	ENSG00000233098.3
3	lnc-DHRS7B-5	chr17:20824465-20824482	ENSG00000233098.3

Variant related genes	Relation type
ENSG00000233098	TF binding region
ENSG00000233098	chromatin interactions
SLITRK4	miRNA target sites

Extended variants
information (count: 91 )
Associated
traits (count: 150 )

Variant overlapped rSNPs/rCNVs (count:91 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs150999979	chr17:20823302-20823303	Enhancers Weak transcription Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs376316581	chr17:20823305-20823306	Enhancers Weak transcription Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs570081205	chr17:20823320-20823321	Enhancers Weak transcription Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs563773016	chr17:20823366-20823367	Enhancers Weak transcription Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs575651887	chr17:20823370-20823371	Enhancers Weak transcription Strong transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs547206641	chr17:20823412-20823413	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs185706719	chr17:20823466-20823467	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs77286372	chr17:20823512-20823513	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs535013324	chr17:20823516-20823517	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs190267112	chr17:20823592-20823593	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs563350865	chr17:20823594-20823595	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs140712250	chr17:20823625-20823626	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs181192593	chr17:20823641-20823642	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs539410443	chr17:20823645-20823646	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs370396268	chr17:20823707-20823708	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs557762918	chr17:20823716-20823717	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs4452013	chr17:20823810-20823811	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs543493857	chr17:20823832-20823833	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs4280307	chr17:20823909-20823910	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs72838175	chr17:20823948-20823949	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs150087349	chr17:20823950-20823951	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs370528866	chr17:20823957-20823958	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs77383201	chr17:20824002-20824003	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs533171791	chr17:20824058-20824059	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs142744037	chr17:20824084-20824085	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs545036526	chr17:20824125-20824126	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs528363086	chr17:20824145-20824146	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs146949772	chr17:20824152-20824153	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs549413268	chr17:20824198-20824199	Enhancers Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs567775505	chr17:20824213-20824214	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs375744511	chr17:20824224-20824225	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs185189220	chr17:20824244-20824245	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs189660408	chr17:20824289-20824290	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs368163540	chr17:20824307-20824308	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs199952701	chr17:20824322-20824323	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs551010936	chr17:20824371-20824372	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
37	rs571995973	chr17:20824372-20824373	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs551336124	chr17:20824392-20824393	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs182440158	chr17:20824402-20824403	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs539321306	chr17:20824406-20824407	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs557507216	chr17:20824471-20824472	Enhancers Weak transcription Flanking Active TSS Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs528162118	chr17:20824507-20824508	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs372786328	chr17:20824561-20824562	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs569629108	chr17:20824584-20824585	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs536750132	chr17:20824618-20824619	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs61203188	chr17:20824652-20824653	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs138487697	chr17:20824656-20824657	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs540856530	chr17:20824675-20824676	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs552734966	chr17:20824711-20824712	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs60606678	chr17:20824768-20824769	Enhancers Weak transcription Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:150)

Disease	PMID	Source
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Breast cancer	17142309	CNVD
Autism	20808228	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:108 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20812200-20824800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr17:20812600-20830800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
3	chr17:20820000-20824000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr17:20820200-20823400	Weak transcription	Muscle Satellite Cultured Cells	--
5	chr17:20820200-20823600	Weak transcription	Duodenum Smooth Muscle	Duodenum
6	chr17:20820200-20823800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr17:20820200-20824200	Weak transcription	Hela-S3	cervix
8	chr17:20820200-20824200	Weak transcription	NHLF	lung
9	chr17:20820200-20827800	Weak transcription	Right Atrium	heart
10	chr17:20820400-20823800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
11	chr17:20820400-20825600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr17:20820400-20825600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr17:20820400-20825600	Weak transcription	NHEK	skin
14	chr17:20820400-20827200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr17:20822800-20824200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
16	chr17:20822800-20824400	Enhancers	Brain Cingulate Gyrus	brain
17	chr17:20823000-20823400	Enhancers	Colon Smooth Muscle	Colon
18	chr17:20823000-20823600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
19	chr17:20823000-20823600	Enhancers	Osteobl	bone
20	chr17:20823000-20823800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr17:20823000-20824400	Enhancers	Brain Anterior Caudate	brain
22	chr17:20823000-20824600	Enhancers	Brain Hippocampus Middle	brain
23	chr17:20823200-20823400	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
24	chr17:20823200-20823400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
25	chr17:20823200-20823400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr17:20823200-20823800	Enhancers	NH-A	brain
27	chr17:20823200-20824000	Enhancers	Brain Inferior Temporal Lobe	brain
28	chr17:20823200-20824000	Enhancers	Ovary	ovary
29	chr17:20823200-20824000	Enhancers	Skeletal Muscle Male	skeletal muscle
30	chr17:20823200-20824000	Enhancers	HSMMtube	muscle
31	chr17:20823200-20824200	Enhancers	Fetal Stomach	stomach
32	chr17:20823200-20824600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
33	chr17:20823200-20825600	Enhancers	NHDF-Ad	bronchial
34	chr17:20823200-20826000	Enhancers	ES-I3 Cell Line	embryonic stem cell
35	chr17:20823200-20826600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr17:20823400-20823800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr17:20823400-20826400	Enhancers	Muscle Satellite Cultured Cells	--
38	chr17:20823400-20827600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
39	chr17:20823400-20831600	Weak transcription	Colon Smooth Muscle	Colon
40	chr17:20823400-20833600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
41	chr17:20823600-20823800	Enhancers	Duodenum Smooth Muscle	Duodenum
42	chr17:20823600-20824000	Flanking Active TSS	Osteobl	bone
43	chr17:20823600-20824400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr17:20823600-20824600	Enhancers	HUES64 Cell Line	embryonic stem cell
45	chr17:20823600-20824600	Enhancers	HSMM	muscle
46	chr17:20823800-20824000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr17:20823800-20824200	Enhancers	HUES6 Cell Line	embryonic stem cell
48	chr17:20823800-20824200	Enhancers	Breast Myoepithelial Primary Cells	Breast
49	chr17:20823800-20824600	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr17:20823800-20824600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links